A detailed history of Lcnb Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Lcnb Corp holds 15,837 shares of ABT stock, worth $1.8 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
15,837
Previous 15,987 0.94%
Holding current value
$1.8 Million
Previous $1.82 Million 9.47%
% of portfolio
0.62%
Previous 0.66%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $15,109 - $16,866
-150 Reduced 0.94%
15,837 $1.65 Million
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $2,957 - $3,265
27 Added 0.17%
15,987 $1.82 Million
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $721 - $883
8 Added 0.05%
15,960 $1.76 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $95,530 - $114,620
-1,000 Reduced 5.9%
15,952 $1.54 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $24,287 - $27,061
241 Added 1.44%
16,952 $1.85 Million
Q1 2023

May 03, 2023

SELL
$96.86 - $114.01 $42,618 - $50,164
-440 Reduced 2.57%
16,711 $1.69 Million
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $38,024 - $44,608
400 Added 2.39%
17,151 $1.88 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $20,803 - $24,086
-215 Reduced 1.27%
16,751 $1.62 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $102,172 - $123,493
-1,001 Reduced 5.57%
16,966 $1.84 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $100,337 - $122,355
880 Added 5.15%
17,967 $2.13 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $35,352 - $43,286
-306 Reduced 1.76%
17,087 $2.41 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $26,948 - $29,812
-231 Reduced 1.31%
17,393 $2.06 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $21,158 - $24,906
200 Added 1.15%
17,624 $2.04 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $13,060 - $15,387
-120 Reduced 0.68%
17,424 $2.09 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $49,350 - $53,777
-470 Reduced 2.61%
17,544 $1.92 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $22,910 - $27,822
-250 Reduced 1.37%
18,014 $1.96 Million
Q2 2020

Aug 12, 2020

SELL
$76.57 - $98.0 $15,313 - $19,600
-200 Reduced 1.08%
18,264 $1.67 Million
Q1 2020

May 11, 2020

SELL
$62.82 - $91.86 $17,275 - $25,261
-275 Reduced 1.47%
18,464 $1.46 Million
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $54,957 - $61,180
-700 Reduced 3.6%
18,739 $1.63 Million
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $23,733 - $25,734
290 Added 1.51%
19,439 $1.63 Million
Q2 2019

Aug 01, 2019

SELL
$72.88 - $85.0 $8,891 - $10,370
-122 Reduced 0.63%
19,149 $1.61 Million
Q1 2019

May 02, 2019

SELL
$66.22 - $80.06 $104,031 - $125,774
-1,571 Reduced 7.54%
19,271 $1.54 Million
Q3 2018

Nov 09, 2018

SELL
$60.81 - $73.36 $34,661 - $41,815
-570 Reduced 2.66%
20,842 $1.53 Million
Q2 2018

Aug 13, 2018

BUY
$57.57 - $63.54 $47,725 - $52,674
829 Added 4.03%
21,412 $1.31 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $23,464 - $26,529
-417 Reduced 1.99%
20,583 $1.23 Million
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $20,398 - $21,838
-380 Reduced 1.78%
21,000 $1.2 Million
Q3 2017

Nov 13, 2017

SELL
$48.06 - $53.64 $12,591 - $14,053
-262 Reduced 1.21%
21,380 $1.14 Million
Q2 2017

Aug 14, 2017

BUY
N/A
21,642
21,642 $1.05 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lcnb Corp Portfolio

Follow Lcnb Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.